Antiplatelet treatment in thromboembolic cerebrovascular diseases.
D001161:Arteriosclerosis / Q000517:prevention & control; D001791:Blood Platelet Disorders / Q000517:prevention & control; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D006937:Hypercholesterolemia / Q000517:prevention & control; D006973:Hypertension / Q000517:prevention & control; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy* / Q000517:prevention & control; D002546:Ischemic Attack, Transient / Q000517:prevention & control; D010974:Platelet Aggregation; D012306:Risk; D000074606:Smoking Prevention
D005343:Fibrinolytic Agents